These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8671806)

  • 1. Non-invasive circulating indicators of bone metabolism in uraemic patients: can they replace bone biopsy?
    Schmidt-Gayk H; Drüeke T; Ritz E
    Nephrol Dial Transplant; 1996 Mar; 11(3):415-8. PubMed ID: 8671806
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative histological studies on the pathogenesis of uremic bone disease.
    Sherrard DJ; Baylink DJ; Wergedal JE; Maloney NA
    J Clin Endocrinol Metab; 1974 Jul; 39(1):119-35. PubMed ID: 4835127
    [No Abstract]   [Full Text] [Related]  

  • 3. The continuous challenge of cardiovascular and bone and bone disease in uremic patients: clinical consequences of hyperphosphatemia and advanced therapeutic approaches.
    Brancaccio D; Zoccali C
    J Nephrol; 2006; 19(1):12-20. PubMed ID: 16523420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating osteoprotegerin affects bone metabolism in dialysis patients with mild secondary hyperparathyroidism.
    Kazama JJ; Omori K; Yamamoto S; Ito Y; Maruyama H; Narita I; Gejyo F; Iwasaki Y; Fukagawa M
    Ther Apher Dial; 2006 Jun; 10(3):262-6. PubMed ID: 16817791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of biochemical markers of bone metabolism in veterinary medicine].
    Carstanjen B
    Berl Munch Tierarztl Wochenschr; 2006; 119(9-10):425-35. PubMed ID: 17007471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possibilities of monitoring bone metabolism in ruminants--an overview of the methods in use.
    Liesegang A
    Acta Vet Scand Suppl; 2003; 97():23-8. PubMed ID: 14621392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of time-course changes of serum bone markers after parathyroidectomy in patients with uraemic hyperparathyroidism.
    Yajima A; Inaba M; Ogawa Y; Tominaga Y; Tanizawa T; Inou T; Otsubo O
    Nephrol Dial Transplant; 2007 Jun; 22(6):1645-57. PubMed ID: 17307749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical markers of bone metabolism: application to understanding bone remodeling in children and adolescents.
    Levine MA
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():661-72. PubMed ID: 12795369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysis bone disease.
    Ritz E; Krempien B; Kuhn H; Heuck F
    Isr J Med Sci; 1971 Mar; 7(3):520. PubMed ID: 5567544
    [No Abstract]   [Full Text] [Related]  

  • 10. Uraemic hyperphosphataemia--what is the therapy of choice?
    Schaefer K
    Nephrol Dial Transplant; 1989; 4(12):1005-7. PubMed ID: 2517320
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental micromorphometric studies on uremic osteodystrophy].
    Krempien B; Ritz E
    Verh Dtsch Ges Pathol; 1970; 54():397-402. PubMed ID: 4104573
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biochemical markers of bone tissue metabolism in cosmonauts after a prolonged spaceflight].
    Morukov BV; Nichiporuk IA; Tret'iakov VS; Larina IM
    Fiziol Cheloveka; 2005; 31(6):73-7. PubMed ID: 16366155
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical significance of adynamic bone disease in uremia.
    Fournier A; Said S; Ghazali A; Sechet A; Ezaitouni F; Marie A; Westeel PF; Morinière P; Boudailliez B
    Adv Nephrol Necker Hosp; 1997; 27():131-66. PubMed ID: 9408446
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone markers--new aspects.
    Cremers S; Bilezikian JP; Garnero P
    Clin Lab; 2008; 54(11-12):461-71. PubMed ID: 19216252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does leptin contribute to uraemic cachexia?
    Bossola M; Muscaritoli M; Tazza L; Rossi Fanelli F; Luciani G
    Nephrol Dial Transplant; 2006 Apr; 21(4):1125-6; author reply 1126. PubMed ID: 16352621
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic bone disease and aluminium contamination in 38 uremic patients. A bone histomorphometric study.
    Pødenphant J; Heaf JG; Joffe P
    Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):1-6. PubMed ID: 3962676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical experience in some aspects of bone markers.
    Bunyaratavej N
    J Med Assoc Thai; 2009 Sep; 92 Suppl5():S116-20. PubMed ID: 19891386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New bone formation and osteoid seam thickness. Appositional rate in patients undergoing renal dialysis.
    Sarnsethsiri P; Jaworski ZF; Shimizu AG; Frost HM
    Arch Pathol; 1969 Jul; 88(1):49-53. PubMed ID: 5793690
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostic significance of morphological changes in biopsies of the pelvic crest (author's transl)].
    Sachs M; Rath FW
    Zentralbl Allg Pathol; 1978; 122(3):226-35. PubMed ID: 676556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Critical study of quantitation in bone histology].
    Bordier P; Kuntz D; Hioco D
    Rhumatologie; 1971 Oct; 23(8):299-301. PubMed ID: 5139389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.